Given the availability of conjugate vaccines against meningococcal disease there is now the potential to effectively control meningococcal disease globally. The authors of this article, published in Vaccine, discuss how optimal control of meningococcal disease will require both the public will and public policy to best serve this goal. They argue that decision as to what ages to target and which schedules to use should not only take into account the cost of the program, but also the severity of the disease and the high level public concern regarding meningococcal disease. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)

Author(s): Black SB, Plotkin SA

Published: 2012

Resource types: Peer-reviewed journal

Diseases: Meningococcus

Topics: Advocacy and communications; Introduction and service delivery; Disease burden and surveillance; Disease/vaccine specific information

Regions: Global